Dow Jones

38 589,16

-0,15%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
CV Therapeutics (MM) (CVTX)
CV Therapeutics (MM) (CVTX) Actualités

CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:CVTX

1 2 3 4 5 6 7 8 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
17/04/2009	23h01	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	NASDAQ:CVTX	CV Therapeutics (MM)
17/04/2009	22h32	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CVTX	CV Therapeutics (MM)
17/04/2009	22h15	Business Wire	Gilead Sciences Completes Acquisition of CV Therapeutics	NASDAQ:CVTX	CV Therapeutics (MM)
17/04/2009	19h29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CVTX	CV Therapeutics (MM)
15/04/2009	21h54	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:CVTX	CV Therapeutics (MM)
14/04/2009	12h06	Edgar (US Regulatory)	Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:CVTX	CV Therapeutics (MM)
09/04/2009	22h53	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:CVTX	CV Therapeutics (MM)
09/04/2009	21h11	Edgar (US Regulatory)	Schedule 13G	NASDAQ:CVTX	CV Therapeutics (MM)
08/04/2009	16h49	Marketwired	AnalystChoice.com Free Investment Opinion on PPDI, MEDX, CVTX and OSIP	NASDAQ:CVTX	CV Therapeutics (MM)
06/04/2009	22h12	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:CVTX	CV Therapeutics (MM)
18/03/2009	22h05	Marketwired	CV Therapeutics' Board of Directors Recommends Stockholders Accept Gilead Sciences' $20.00 per Share Cash Tender Offer	NASDAQ:CVTX	CV Therapeutics (MM)
18/03/2009	21h44	Edgar (US Regulatory)	Statement of Ownership: Solicitation (SC 14D9)	NASDAQ:CVTX	CV Therapeutics (MM)
18/03/2009	21h42	Edgar (US Regulatory)	Tender offer statement by Third Party (SC TO-T)	NASDAQ:CVTX	CV Therapeutics (MM)
18/03/2009	18h53	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CVTX	CV Therapeutics (MM)
18/03/2009	18h52	Edgar (US Regulatory)	Written communication relating to an issuer or third party (SC TO-C)	NASDAQ:CVTX	CV Therapeutics (MM)
17/03/2009	14h07	Marketwired	Run of 100% Profitable Stock Alerts Marches on for BullTrade	NASDAQ:CVTX	CV Therapeutics (MM)
16/03/2009	22h13	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)	NASDAQ:CVTX	CV Therapeutics (MM)
16/03/2009	21h57	Dow Jones News	MARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&A	NASDAQ:CVTX	CV Therapeutics Inc.
16/03/2009	21h01	Marketwired	CV Therapeutics Announces Presentations at the American College of Cardiology 58th Annual Scientific Session	NASDAQ:CVTX	CV Therapeutics (MM)
16/03/2009	20h01	Dow Jones News	UPDATE: US Drug Sector Rises After Bernanke Comments	NASDAQ:CVTX	CV Therapeutics Inc.
16/03/2009	19h49	Dow Jones News	MARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&A	NASDAQ:CVTX	CV Therapeutics Inc.
16/03/2009	16h10	Dow Jones News	Drug Sector Rises As Fed Chief Bernanke's Upbeat On Recession	NASDAQ:CVTX	CV Therapeutics Inc.
16/03/2009	10h12	Dow Jones News	UPDATE:Astellas Pharma Abandons Offer To Buy CV Therapeutics	NASDAQ:CVTX	CV Therapeutics Inc.
16/03/2009	08h08	Dow Jones News	Astellas Pharma: Withdrawing Offer To Buy CV Therapeutics	NASDAQ:CVTX	CV Therapeutics Inc.
16/03/2009	07h42	Business Wire	Astellas to Terminate Offer for CV Therapeutics	NASDAQ:CVTX	CV Therapeutics (MM)
13/03/2009	13h45	Dow Jones News	Genentech-Roche Deal Shows Attraction Of Biotech Assets	NASDAQ:CVTX	CV Therapeutics Inc.
12/03/2009	22h03	Edgar (US Regulatory)	Written communication by the subject company relating to a third party tender offer (SC14D9C)	NASDAQ:CVTX	CV Therapeutics (MM)
12/03/2009	19h15	PR Newswire (US)	CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer	NASDAQ:CVTX	CV Therapeutics (MM)
12/03/2009	15h06	Dow Jones News	UPDATE: Gilead To Buy CV Therapeutics For $1.4 Billion	NASDAQ:CVTX	CV Therapeutics Inc.
12/03/2009	14h22	Dow Jones News	Gilead To Buy CV Therapeutics For $1.4 Billion In White-Knight Bid	NASDAQ:CVTX	CV Therapeutics Inc.